Credo Capital Management’s Myriad Genetics MYGN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2013 Q4	–	Sell	-386	Closed	-$9K	–	180
2013 Q3	$9K	Sell	386 -228	-37%	-$5.32K	0.02%	159
2013 Q2	$16K	Buy	+614	New	+$16K	0.01%	129